Back to Search
CHELSIE VELIKOVSKY, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1548644875Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Structure of a lamprey variable lymphocyte receptor in complex with a protein antigen.
PMID 19543291·Nat Struct Mol Biol·2009
7-preclinical
Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.
PMID 17950006·Immunity·2007
7-preclinical
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.
PMID 14500496·Infect Immun·2003
7-preclinical
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.
PMID 11953389·Infect Immun·2002
7-preclinical
Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.
PMID 11033013·J Immunol Methods·2000
7-preclinical
High-affinity lamprey VLRA and VLRB monoclonal antibodies.
PMID 19625627·Proc Natl Acad Sci U S A·2009
7-preclinical
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
PMID 17442465·Vaccine·2007
7-preclinical
Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
PMID 17428946·Clin Vaccine Immunol·2007
7-preclinical
Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation.
PMID 15613487·Proc Natl Acad Sci U S A·2005
8-other
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
PMID 16299302·Infect Immun·2005
7-preclinical
Sedimentation velocity analysis of heterogeneous protein-protein interactions: Lamm equation modeling and sedimentation coefficient distributions c(s).
PMID 15863475·Biophys J·2005
8-other
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
PMID 16177328·Infect Immun·2005
7-preclinical
Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cgamma1.
PMID 16061254·J Mol Biol·2005
8-other
Structural basis for differential recognition of tyrosine-phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads.
PMID 15029250·EMBO J·2004
7-preclinical
Entropically assisted carbohydrate recognition by a natural killer cell-surface receptor.
PMID 15515091·Chembiochem·2004
8-other
Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis.
PMID 11874879·Clin Diagn Lab Immunol·2002
7-preclinical
Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.
PMID 11858876·Vaccine·2002
7-preclinical
Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis.
PMID 12134263·J Infect Dis·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 612 S 12TH ST
FORT SMITH, AR 72901 - Phone
- (479) 423-3193
Quick Facts
- NPI
- 1548644875
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile